New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:33 EDTTWTowers Watson upgraded to Conviction Buy from Buy at Goldman
Goldman added Towers Watson to the Conviction Buy List and maintains its Buy rating and $134 price target. The firm views Towers Watson as the best way to gain exposure to private healthcare exchange growth.
News For TW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
15:58 EDTTWTowers Watson holders may vote against Willis Group merger, Bloomberg says
Towers Watson (TW) shareholders are planning on voting against the $8.7B merger with Willis Group (WSH), reports Bloomberg, citing people with knowledge of the matter. Reference Link
15:10 EDTTWTowers Watson holders said to plan to vote against Willis deal, Bloomberg says
Large shareholders of Towers Watson (TW) are also considering a vote against the board's re-election, according to Bloomberg, citing sources.
12:26 EDTTWDriehaus: Towers Watson-Willis Group transaction will 'destroy' TW value
Subscribe for More Information
October 1, 2015
08:11 EDTTWTowers Watson completes acquisition of Brovada
Towers Watson announced the completion of its acquisition of Brovada, a Canadian technology provider for property & casualty insurers and brokerages. The acquisition will enhance Towers Watson's capabilities across its portfolio of software targeted at the P&C market. Brovada will operate as a separate unit within the company's Risk Consulting and Software business, part of its Risk and Financial Services business segment. Brovada's founder and CEO, Karl Greenlaw, will continue to lead the Brovada team.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use